ZOLINZA (vorinostat) Patient Assistance Program

Don’t let the high cost of brand specialty cutaneous T-cell lymphoma therapy disrupt your treatment. We help eligible patients access Zolinza (vorinostat) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Zolinza Prescription Assistance Program?

Zolinza PAP for CTCL patients.

Eligibility, oncology/dermatology coordination.

AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens (brand)

~$17,500

Save substantially

CVS Pharmacy (brand)

~$18,000

Save substantially

Walmart (brand)

~$14,500

Save substantially

Costco (brand)

~$14,200

Save substantially

Generic vorinostat

~$3,500

Generic low

*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Zolinza Prescription Program?

Generic vorinostat substantially cheaper than brand Zolinza.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Zolinza:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Coupon cards expire and require constant renewal
  • Still $14,000–$18,000 per month even with the best discount

  • Can’t be used with Medicare, Medicaid, or government insurance
  •  

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly through the assistance program
  • We manage all paperwork, refills, and annual renewals
  • If denied, we explore alternative savings on your behalf

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Zolinza assistance.

Not sure if you qualify?  Our pre-qualification check is completely free. If we can’t help, you won’t be charged.

Understanding Zolinza:

Zolinza (vorinostat) is oral HDAC inhibitor for advanced CTCL — mycosis fungoides or Sézary syndrome refractory to prior therapy. Modulates gene expression by inhibiting histone and protein deacetylation.

Tykerb (lapatinib) is an oral tyrosine kinase inhibitor that targets both HER2 (ErbB2) and EGFR (ErbB1). It is used for advanced or metastatic HER2-positive breast cancer, typically in combination with capecitabine or letrozole.

How Zolinza Works:

HDACs remove acetyl groups from histone and non-histone proteins; HDAC inhibition increases acetylation, alters gene expression in cancer cells, induces cell cycle arrest and apoptosis.

Vorinostat induces tumor cell differentiation, growth arrest, and apoptosis particularly in T-cell lymphomas. Modest response rates (~30% in CTCL); used in refractory disease.

Form and use:

Zolinza 400 mg once daily by mouth, with food. Until disease progression or unacceptable toxicity.

Generic availability:

Generic vorinostat now available. Other CTCL options: romidepsin (Istodax IV), brentuximab vedotin (CD30+), bexarotene (Targretin RXR agonist, generic), mogamulizumab (CCR4), ECP, narrowband UVB, local skin-directed therapy, methotrexate, interferon.

Warnings:

Pulmonary embolism/DVT (CBC and pulmonary monitoring), thrombocytopenia and anemia, GI toxicity (nausea, diarrhea, anorexia), QT prolongation, dehydration, hyperglycemia.

FAQ (Frequently Asked Questions)

Cost?

Brand $14,000–$18,000/month. Generic vorinostat ~$3,500/month.

Yes, FDA-approved bioequivalent.

Mycosis fungoides (most common CTCL) and Sézary syndrome (leukemic variant). Zolinza for advanced refractory disease.

Romidepsin IV HDAC inhibitor. Adcetris for CD30+. Targretin oral RXR agonist. Poteligeo anti-CCR4 IV.

Generic vorinostat much cheaper. Other CTCL options. Cutaneous Lymphoma Foundation may help.

Take Control of Your Medication Costs

Generic vorinostat much cheaper. Check eligibility today.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process